1. MiR-29a: a potential therapeutic target and promising biomarker in tumors
   Jin-yan Wang et al, 2018, Bioscience Reports CrossRef
2. Clinical role of MiRNA 29a and MiRNA 335 on breast cancer management: their relevance to MMP2 protein level
   Elham Ali Ahmed et al, 2022, Archives of Physiology and Biochemistry CrossRef
3. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P
   Chiao-Chun Liao et al, 2018, Autophagy CrossRef
4. miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway
   Zhi-hua Li et al, 2017, Oncotarget CrossRef
5. The Role of miR-29s in Human Cancers—An Update
   Thuy T. P. Nguyen et al, 2022, Biomedicines CrossRef